These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8322268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor.
    Glueck CJ, Glueck HI, Welch M, Freiberg R, Tracy T, Hamer T, Stroop D.
    Thromb Haemost; 1994 Feb; 71(2):195-8. PubMed ID: 8191398
    [Abstract] [Full Text] [Related]

  • 3. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.
    Glueck CJ, Freiberg R, Glueck HI, Tracy T, Stroop D, Wang Y.
    Am J Hematol; 1995 Apr; 48(4):213-20. PubMed ID: 7717367
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypofibrinolysis: a common, major cause of osteonecrosis.
    Glueck CJ, Freiberg R, Glueck HI, Henderson C, Welch M, Tracy T, Stroop D, Hamer T, Sosa F, Levy M.
    Am J Hematol; 1994 Feb; 45(2):156-66. PubMed ID: 8141121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.
    Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P.
    Clin Orthop Relat Res; 1997 Jan; (334):43-56. PubMed ID: 9005895
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Jan; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 9. Procoagulants and osteonecrosis.
    Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ.
    J Rheumatol; 2003 Apr; 30(4):783-91. PubMed ID: 12672200
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
    Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH.
    Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 15. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A, Wiman B, Schulman S.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
    Hellebrekers BW, Trimbos-Kemper GC, Bakkum EA, Trimbos JB, Declerck PJ, Kooistra T, Emeis JJ.
    Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.